Lentiviral vector platform for improved erythropoietin expression concomitant with shRNA mediated host cell elastase down regulation

Andersen, 2002, Recombinant protein expression for therapeutic applications, Curr. Opin. Biotechnol., 13, 117, 10.1016/S0958-1669(02)00300-2 Baldi, 2005, Transient Gene Expression in Suspension HEK293 Cells: Application to Large Scale Protein Production, Biotechnol. Prog., 21, 148, 10.1021/bp049830x Bandaranayake, 2011, Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors, Nucleic Acids Res., 39, 10.1093/nar/gkr706 Chande, 2013, Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility, Plasmid, 69, 90, 10.1016/j.plasmid.2012.09.006 da Rosa, 2012, SK-HEP cells and lentiviral vector for production of human recombinant factor VIII, Biotechnol. Lett., 34, 1435, 10.1007/s10529-012-0925-4 Gaillet, 2010, High level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch, Biotechnol. Bioeng., 106, 203 Gustafsson, 2012, Engineering genes for predictable protein expression, Protein Expr. Purif., 83, 37, 10.1016/j.pep.2012.02.013 Henry, 2011, Enhanced glycoprotein production in HEK-293 cells expressing pyruvate carboxylase, Metab. Eng., 13, 499, 10.1016/j.ymben.2011.05.004 Jelkmann, 2007, Control of erythropoietin gene expression and its use in medicine, Methods Enzymol., 435, 179, 10.1016/S0076-6879(07)35010-6 Kaufmann, 2003, Metabolic engineering of mammalian cells for higher protein yield, New Compr. Biochem., 38, 457, 10.1016/S0167-7306(03)38027-5 Kwaks, 2006, Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells, Trends Biotechnol., 24, 137, 10.1016/j.tibtech.2006.01.007 Loignon, 2008, Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells, BMC Biotechnol., 8, 65, 10.1186/1472-6750-8-65 Neri, 2002, Erythropoietin (EPO)-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3, 4, 5) trisphosphate, Cell. Signal., 14, 21, 10.1016/S0898-6568(01)00224-8 Ng, 2010, Evaluating regulatory elements of human cytomegalovirus major immediate early gene for enhancing transgene expression levels in CHO K1 and HEK293 cells, J. Biotechnol., 147, 160, 10.1016/j.jbiotec.2010.02.022 Oberbek, 2011, Generation of stable, high-producing cho cell lines by lentiviral vector mediated gene transfer in serum free suspension culture, Biotechnol. Bioeng., 108, 600, 10.1002/bit.22968 Pei, 2006, On the art of identifying effective and specific siRNAs, Nat. Methods, 3, 670, 10.1038/nmeth911 Peng, 2010, The vesicle-trafficking protein munc18b increases the secretory capacity of mammalian cells, Metab. Eng., 12, 18, 10.1016/j.ymben.2009.08.007 Santhosh, 2008, A lentiviral vector with novel multiple cloning sites: stable transgene expression in vitro and in vivo, Biochem. Biophys. Res. Commun., 371, 546, 10.1016/j.bbrc.2008.04.106 Spencer, 2011, Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII, Mol. Ther., 19, 302, 10.1038/mt.2010.239 Thomas, 2005, HEK293 cell line: a vehicle for the expression of recombinant proteins, J. Pharmacol. Toxicol. Methods, 51, 187, 10.1016/j.vascn.2004.08.014 Tsuji, 1992, Chinese hamster ovary cells produce an enzyme that nicks heat-labile enterotoxin from enterotoxigenic Escherichia coli, Eur. J. Epidemiol., 8, 74, 10.1007/BF00146374 Venkatraman, 2009, A sequence and structure based method to predict putative substrates, functions and regulatory networks of endo proteases, PLoS ONE, 4, e5700, 10.1371/journal.pone.0005700 Walsh, 2006, Post-translational modifications in the context of therapeutic proteins, Nat. Biotechnol., 24, 1241, 10.1038/nbt1252 Warner, 1999, Enhancing therapeutic glycoprotein production in Chinese hamster ovary cells by metabolic engineering endogenous gene control with antisense DNA and gene targeting, Glycobiology, 9, 841, 10.1093/glycob/9.9.841 Wu, 2009, RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells, Biotechnol. Adv., 27, 417, 10.1016/j.biotechadv.2009.03.002 Wurm, 2004, Production of recombinant protein therapeutics in cultivated mammalian cells, Nat. Biotechnol., 22, 1393, 10.1038/nbt1026